Anaerobiosis of Pseudomonas aeruginosa: Implications for treatments of airway infection

Journal of Bacteriology and Virology

Volumn 40, Issue 2, 2010, Pages 59-66

  Yoon, Sang Sun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Anaerobic environments; Biofilm; Pseudomonas aeruginosa; Quorum sensing

Indexed keywords

CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TRANSACTIVATOR PROTEIN; UBIQUINOL CYTOCHROME C REDUCTASE;

ADAPTATION; ANAEROBIC GROWTH; ANAEROBIC METABOLISM; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOFILM; ELECTRON TRANSPORT; HISTOPATHOLOGY; HUMAN; INFECTION SENSITIVITY; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RESPIRATORY TRACT INFECTION; REVIEW;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 79951866265     PISSN: 15982467     EISSN: None     Source Type: Journal    
DOI: 10.4167/jbv.2010.40.2.59     Document Type: Review

References (71)

1. Yoon SS, Hassett DJ. Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets. Expert Rev Anti Infect Ther 2004;2:611-623.
2. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2000;2:1051-1060.
3. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 2002; 3:593-603.
4. Yoon SS, Karabulut AC, Lipscomb JD, Hennigan RF, Lymar S V, Groce SL, et al. Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration. EMBO J 2007;26:3662-3672.
5. Parsek MR, Tolker-Nielsen T. Pattern formation in Pseudomonas aeruginosa biofilms. Curr Opin Microbiol 2008;11:560-566.
6. Aparna MS, Yadav S. Biofilms: microbes and disease. Braz J Infect Dis 2008;12:526-530.
7. Filloux A, Vallet I. Biofilm: set-up and organization of a bacterial community. Med Sci (Paris) 2003;19:77-83.
8. Hassett DJ, Elkins JG, Ma JF, McDermott TR. Pseudomonas aeruginosa biofilm sensitivity to biocides: use of hydrogen peroxide as model antimicrobial agent for examining resistance mechanisms. Methods Enzymol 1999;310:599-608.
9. Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, et al. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol 2005;43:5085-5090.
10. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:135-138.
11. Teitzel GM, Parsek MR. Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl Environ Microbiol 2003;69:2313-2320.
12. Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 2003; 171:4329-4339.
13. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006;43 Suppl 2:S49-S56.
14. Wiedemann B, Heisig P. Mechanisms of quinolone resistance. Infection 1994;22 Suppl 2:S73-S79.
15. Poole K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol 2002;92 Suppl:55S-64S.
16. Mariani-Kurkdjian P, Bingen E. Pseudomonas aeruginosa: resistance to antibiotics. Arch Pediatr 2006; 13 Suppl 1:S5-S9.
17. Lazdunski A, Guzzo J, Filloux A, Bally M, Murgier M. Secretion of extracellular proteins by Pseudomonas aeruginosa. Biochimie 1990;72:147-156.
18. Heck LW, Alarcon PG, Kulhavy RM, Morihara K, Russell MW, Mestecky JF. Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J Immunol 1990; 144:2253-2257.
19. Wretlind B, Pavlovskis OR. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections. Scand J Infect Dis Suppl 1981; 29:13-19.
20. Guzzo J, Duong F, Wandersman C, Murgier M, Lazdunski A. The secretion genes of Pseudomonas aeruginosa alkaline protease are functionally related to those of Erwinia chrysanthemi proteases and Escherichia coli alpha-haemolysin. Mol Microbiol 1991;5:447-453.
21. Pollack M. The role of exotoxin A in pseudomonas disease and immunity. Rev Infect Dis 1983;5 Suppl 5:S979-S984.
22. Cryz SJ, Jr., Furer E, Sadoff JC, Germanier R, Pastan I, Willingham MC, et al. Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins. Rev Infect Dis 1987;9 Suppl 5:S644-S649.
23. Berk RS, Brown D, Coutinho I, Meyers D. In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa. Infect Immun 1987;55:1728 -1730.
24. Berka RM, Vasil ML. Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization. J Bacteriol 1982;152: 239-245.
25. Lau GW, Hassett DJ, Ran H, Kong F. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 2004;10:599-606.
26. Antunes MB, Cohen NA. Mucociliary clearance--a critical upper airway host defense mechanism and methods of assessment. Curr Opin Allergy Clin Immunol 2007;7:5-10.
27. Fokkens WJ, Scheeren RA. Upper airway defence mechanisms. Paediatr Respir Rev 2000;1:336-341.
28. Umeki S. Primary mucociliary transport failure. Respiration 1988;54:220-225.
29. Tiddens HA, Donaldson SH, Rosenfeld M, Pare PD. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively? Pediatr Pulmonol 2010;45:107-117.
30. Frey HR, Russi EW. Bronchiectasis--current aspects of an old disease. Schweiz Med Wochenschr 1997;127: 219-230.
31. Clarke SW. Management of mucus hypersecretion. Eur J Respir Dis Suppl 1987;153:136-144.
32. Reynolds HY. Host defense impairments that may lead to respiratory infections. Clin Chest Med 1987;8:339 -358.
33. Fahy J V, Schuster A, Ueki I, Boushey HA, Nadel JA. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases. Am Rev Respir Dis 1992;146: 1430-1433.
34. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003;361: 681-689.
35. Bangel N, Dahlhoff C, Sobczak K, Weber WM, Kusche-Vihrog K. Upregulated expression of ENaC in human CF nasal epithelium. J Cyst Fibros 2008;7:197 -205.
36. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002;109:317-325.
37. Meyer KC, Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993;121:654-661.
38. Jagger KS, Robinson DL, Franz MN, Warren RL. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients. J Clin Microbiol 1982;15:1054-1058.
39. Kerscher S, Drose S, Zickermann V, Brandt U. The three families of respiratory NADH dehydrogenases. Results Probl Cell Differ 2008;45:185-222.
40. Mulkidjanian AY. Proton translocation by the cytochrome bc1 complexes of phototrophic bacteria: introducing the activated Q-cycle. Photochem Photobiol Sci 2007; 6:19-34.
41. Tsukihara T., Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, et al. Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8 A. Science 1995;269:1069-1074.
42. Gresser MJ, Myers JA, Boyer PD. Catalytic site cooperativity of beef heart mitochondrial F1 adenosine triphosphatase. Correlations of initial velocity, bound intermediate, and oxygen exchange measurements with an alternating three-site model. J Biol Chem 1982;257: 12030-12038.
43. Linnane SJ, Keatings VM, Costello CM, Moynihan JB, O'Connor CM, Fitzgerald MX, et al. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 1998;158:207-212.
44. Jones KL, Hegab AH, Hillman BC, Simpson KL, Jinkins PA, Grisham MB, et al. Elevation of nitro-tyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol 2000;30:79-85.
45. Costerton JW, Stewart PS, Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-1322.
46. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 1998;30:295-304.
47. Sriramulu DD, Lunsdorf H, Lam JS, Romling U. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 2005;54:667-676.
48. Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 2007;10:644-648.
49. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003; 426:306-310.
50. Sadovskaya I, Vinogradov E, Li J, Hachani A, Kowalska K, Filloux A. High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: the ndvB gene is involved in the production of highly glyceroL-phosphorylated {beta}-(1->3)-glucans, which bind aminoglycosides. Glycobiology 2010;20:895-904.
51. Xu KD, Stewart PS, Xia F, Huang CT, McFeters GA. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ Microbiol 1998;64:4035-4039.
52. de Kievit TR. Quorum sensing in Pseudomonas aeruginosa biofilms. Environ Microbiol 2009;11:279 -288.
53. Storey DG, Ujack EE, Rabin HR, Mitchell I. Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA, lasB, and toxA in chronic lung infections associated with cystic fibrosis. Infect Immun 1998;66:2521-2528.
54. Pearson JP, Pesci EC, Iglewski BH. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol 1997;179:5756-5767.
55. Howe TR, Iglewski BH. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model. Infect Immun 1984;43:1058-1063.
56. Hassett DJ, Ma JF, Elkins JG, McDermott TR, Ochsner UA, West SE, et al. Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol 1999;34:1082-1093.
57. Clatworthy AE, Lee JS, Leibman M, Kostun Z, Davidson AJ, Hung DT. Pseudomonas aeruginosa infection of zebrafish involves both host and pathogen determinants. Infect Immun 2009;77:1293-1303.
58. Papaioannou E, Wahjudi M, Nadal-Jimenez P, Koch G, Setroikromo R, Quax WJ. Quorum-quenching acylase reduces the virulence of Pseudomonas aeruginosa in a Caenorhabditis elegans infection model. Antimicrob Agents Chemother 2009;53:4891-4897.
59. Tang HB, DiMango E, Bryan R, Gambello M, Iglewski BH, Goldberg JB, et al. Contribution of specific Pseudomonas aeruginosa virulence factors to patho-genesis of pneumonia in a neonatal mouse model of infection. Infect Immun 1996;64:37-43.
60. Sawa T, Ohara M, Kurahashi K, Twining SS, Frank DW, Doroques DB, et al. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun 1998;66:3242-3249.
61. Chun CK, Ozer EA, Welsh MJ, Zabner J, Greenberg E P. Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc Natl Acad Sci U S A 2004;101:3587-3590.
62. Gambello MJ, Iglewski BH. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 1991;173:3000-3009.
63. Pesci EC, Pearson J P, Seed PC, Iglewski BH. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 1997;179:3127-3132.
64. Pesci EC, Milbank JB, Pearson JP, McKnight S, Kende AS, Greenberg E P, et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1999;96:11229 -11234.
65. Diggle SP, Cornelis P, Williams P, Camara M. 4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. Int J Med Microbiol 2006;296:83-91.
66. Calfee MW, Coleman JP, Pesci EC. Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2001;98:11633-11637.
67. McKnight SL, Iglewski BH, Pesci EC. The Pseudomonas quinolone signal regulates rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 2000; 182:2702-2708.
68. Jensen V, Lons D, Zaoui C, Bredenbruch F, Meissner A, Dieterich G. RhlR expression in Pseudomonas aeruginosa is modulated by the Pseudomonas quinolone signal via PhoB-dependent and -independent pathways. J Bacteriol 2006;188:8601-8606.
69. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Deziel E, Smith EE, et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 2007; 64:512-533.
70. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW, et al. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros 2009;8:66-70.
71. Hoffman LR, Richardson AR, Houston LS, Kulasekara HD, Martens-Habbena W, Klausen M, et al. Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 2010;6:e1000712.